Treatment of angioedema.
D000799:Angioedema / Q000188:drug therapy* / Q000276:immunology; D003169:Complement Inactivator Proteins / Q000378:metabolism; D003613:Danazol / Q000627:therapeutic use; D006801:Humans
D003169:Complement Inactivator Proteins; D003613:Danazol